{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:06:38Z","timestamp":1763539598454,"version":"3.45.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CJD Support Group Network"},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1083309","APP1105784"],"award-info":[{"award-number":["APP1083309","APP1105784"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05511-2","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:04:03Z","timestamp":1763539443000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stereotaxic Delivery of M1000 Prions to the Hippocampus Induces Related Behavioural and Cognitive Changes Consistent with Acute Neurotoxic Effects"],"prefix":"10.1007","volume":"63","author":[{"given":"Matteo","family":"Senesi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Adlard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"7335","key":"5511_CR1","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature09768","volume":"470","author":"MK Sandberg","year":"2011","unstructured":"Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J (2011) Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470(7335):540\u2013542","journal-title":"Nature"},{"key":"5511_CR2","doi-asserted-by":"crossref","unstructured":"Sandberg MK, Al-Doujaily H, Sharps B, De Oliveira MW, Schmidt C, Richard-Londt A, Lyall S, Linehan JM et al (2014) Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked. Nat Commun 5:4347","DOI":"10.1038\/ncomms5347"},{"issue":"7","key":"5511_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nn.3120","volume":"15","author":"A Aguzzi","year":"2012","unstructured":"Aguzzi A, Falsig J (2012) Prion propagation, toxicity and degradation. Nat Neurosci 15(7):936\u2013939","journal-title":"Nat Neurosci"},{"key":"5511_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.arr.2017.03.007","volume":"36","author":"M Senesi","year":"2017","unstructured":"Senesi M, Lewis V, Kim JH, Adlard PA, Finkelstein DI, Collins SJ (2017) In vivo prion models and the disconnection between transmissibility and neurotoxicity. Ageing Res Rev 36:156\u2013164. https:\/\/doi.org\/10.1016\/j.arr.2017.03.007","journal-title":"Ageing Res Rev"},{"issue":"4","key":"5511_CR5","doi-asserted-by":"publisher","first-page":"e1007712","DOI":"10.1371\/journal.ppat.1007712","volume":"15","author":"ST Foliaki","year":"2019","unstructured":"Foliaki ST, Lewis V, Islam AMT, Ellett LJ, Senesi M, Finkelstein DI, Roberts B, Lawson VA et al (2019) Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc. PLoS Pathog 15(4):e1007712. https:\/\/doi.org\/10.1371\/journal.ppat.1007712","journal-title":"PLoS Pathog"},{"issue":"8","key":"5511_CR6","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1371\/journal.ppat.0030125","volume":"3","author":"S Simoneau","year":"2007","unstructured":"Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J et al (2007) In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 3(8):e125","journal-title":"PLoS Pathog"},{"issue":"8","key":"5511_CR7","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1073\/pnas.1118090109","volume":"109","author":"M Zhou","year":"2012","unstructured":"Zhou M, Ottenberg G, Sferrazza GF, Lasmezas CI (2012) Highly neurotoxic monomeric alpha-helical prion protein. Proc Natl Acad Sci U S A 109(8):3113\u20133118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"5511_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.freeradbiomed.2011.03.035","volume":"51","author":"CL Haigh","year":"2011","unstructured":"Haigh CL, McGlade AR, Lewis V, Masters CL, Lawson VA, Collins SJ (2011) Acute exposure to prion infection induces transient oxidative stress progressing to be cumulatively deleterious with chronic propagation in vitro. Free Radic Biol Med 51(3):594\u2013608. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.03.035","journal-title":"Free Radic Biol Med"},{"key":"5511_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep20762","volume":"6","author":"GS Victoria","year":"2016","unstructured":"Victoria GS, Arkhipenko A, Zhu S, Syan S, Zurzolo C (2016) Astrocyte-to-neuron intercellular prion transfer is mediated by cell-cell contact. Sci Rep 6:20762","journal-title":"Sci Rep"},{"issue":"1","key":"5511_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/bmb\/66.1.161","volume":"66","author":"AF Hill","year":"2003","unstructured":"Hill AF, Collinge J (2003) Subclinical prion infection in humans and animals. Br Med Bull 66(1):161\u2013170","journal-title":"Br Med Bull"},{"issue":"5","key":"5511_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.brainresbull.2005.09.010","volume":"68","author":"MW Brazier","year":"2006","unstructured":"Brazier MW, Lewis V, Ciccotosto GD, Klug GM, Lawson VA, Cappai R, Ironside JW, Masters CL et al (2006) Correlative studies support lipid peroxidation is linked to PrP(res) propagation as an early primary pathogenic event in prion disease. Brain Res Bull 68(5):346\u2013354","journal-title":"Brain Res Bull"},{"key":"5511_CR12","doi-asserted-by":"publisher","first-page":"106075","DOI":"10.1016\/j.nbd.2023.106075","volume":"180","author":"M Senesi","year":"2023","unstructured":"Senesi M, Lewis V, Adlard PA, Finkelstein DI, Kim JH, Collins SJ (2023) Tailored behavioural tests reveal early and progressive cognitive deficits in M1000 prion disease. Neurobiol Dis 180:106075","journal-title":"Neurobiol Dis"},{"key":"5511_CR13","doi-asserted-by":"crossref","unstructured":"Chesebro B, Striebel J, Rangel A, Phillips K, Hughson A, Caughey B, Race B (2015) Early generation of new PrPSc on blood vessels after brain microinjection of scrapie in mice. MBio 6(5):e01419\u201315","DOI":"10.1128\/mBio.01419-15"},{"issue":"3","key":"5511_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrn3677","volume":"15","author":"DM Bannerman","year":"2014","unstructured":"Bannerman DM, Sprengel R, Sanderson DJ, McHugh SB, Rawlins JN, Monyer H, Seeburg PH (2014) Hippocampal synaptic plasticity, spatial memory and anxiety. Nat Rev Neurosci 15(3):181\u2013192","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"5511_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1006\/nlme.1999.3919","volume":"73","author":"F Dellu","year":"2000","unstructured":"Dellu F, Contarino A, Simon H, Koob GF, Gold LH (2000) Genetic differences in response to novelty and spatial memory using a two-trial recognition task in mice. Neurobiol Learn Mem 73(1):31\u201348","journal-title":"Neurobiol Learn Mem"},{"key":"5511_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113306","volume":"329","author":"CHJ Park","year":"2020","unstructured":"Park CHJ, Ganella DE, Perry CJ, Kim JH (2020) Dissociated roles of dorsal and ventral hippocampus in recall and extinction of conditioned fear in male and female juvenile rats. Exp Neurol 329:113306","journal-title":"Exp Neurol"},{"issue":"2","key":"5511_CR17","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nbd.2004.08.015","volume":"18","author":"C Cunningham","year":"2005","unstructured":"Cunningham C, Deacon RM, Chan K, Boche D, Rawlins JN, Perry VH (2005) Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol Dis 18(2):258\u2013269","journal-title":"Neurobiol Dis"},{"issue":"10","key":"5511_CR18","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1046\/j.1460-9568.2003.02662.x","volume":"17","author":"C Cunningham","year":"2003","unstructured":"Cunningham C, Deacon R, Wells H, Boche D, Waters S, Diniz CP, Scott H, Rawlins JN et al (2003) Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur J Neurosci 17(10):2147\u20132155","journal-title":"Eur J Neurosci"},{"issue":"3","key":"5511_CR19","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nprot.2006.170","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon RM (2006) Assessing nest building in mice. Nat Protoc 1(3):1117\u20131119","journal-title":"Nat Protoc"},{"issue":"1","key":"5511_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbr.2004.06.013","volume":"157","author":"RM Deacon","year":"2005","unstructured":"Deacon RM, Reisel D, Perry VH, Nicholas J, Rawlins P (2005) Hippocampal scrapie infection impairs operant DRL performance in mice. Behav Brain Res 157(1):99\u2013105","journal-title":"Behav Brain Res"},{"issue":"2","key":"5511_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1046\/j.0953-816x.2001.01645.x","volume":"14","author":"K Guenther","year":"2001","unstructured":"Guenther K, Deacon RM, Perry VH, Rawlins JN (2001) Early behavioural changes in scrapie-affected mice and the influence of dapsone. Eur J Neurosci 14(2):401\u2013409","journal-title":"Eur J Neurosci"},{"issue":"6","key":"5511_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068062","volume":"8","author":"KJ Hilton","year":"2013","unstructured":"Hilton KJ, Cunningham C, Reynolds RA, Perry VH (2013) Early hippocampal synaptic loss precedes neuronal loss and associates with early behavioural deficits in three distinct strains of prion disease. PLoS ONE 8(6):e68062. https:\/\/doi.org\/10.1371\/journal.pone.0068062","journal-title":"PLoS ONE"},{"issue":"2","key":"5511_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.nbd.2005.12.002","volume":"22","author":"Z Chiti","year":"2006","unstructured":"Chiti Z, Knutsen OM, Betmouni S, Greene JR (2006) An integrated, temporal study of the behavioural, electrophysiological and neuropathological consequences of murine prion disease. Neurobiol Dis 22(2):363\u2013373","journal-title":"Neurobiol Dis"},{"issue":"3","key":"5511_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neuron.2007.01.005","volume":"53","author":"GR Mallucci","year":"2007","unstructured":"Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG et al (2007) Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron 53(3):325\u2013335","journal-title":"Neuron"},{"issue":"5646","key":"5511_CR25","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.1090187","volume":"302","author":"G Mallucci","year":"2003","unstructured":"Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302(5646):871\u2013874","journal-title":"Science"},{"issue":"3","key":"5511_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0922-4106(93)90040-G","volume":"246","author":"WE Muller","year":"1993","unstructured":"Muller WE, Ushijima H, Schroder HC, Forrest JM, Schatton WF, Rytik PG, Heffner-Lauc M (1993) Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur J Pharmacol 246(3):261\u2013267. https:\/\/doi.org\/10.1016\/0922-4106(93)90040-G","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"5511_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ana.410050616","volume":"5","author":"J Tateishi","year":"1979","unstructured":"Tateishi J, Ohta M, Koga M, Sato Y, Kuroiwa Y (1979) Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann Neurol 5(6):581\u2013584","journal-title":"Ann Neurol"},{"issue":"4","key":"5511_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.10336","volume":"52","author":"SJ Collins","year":"2002","unstructured":"Collins SJ, Lewis V, Brazier M, Hill AF, Fletcher A, Masters CL (2002) Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model. Ann Neurol 52(4):503\u2013506. https:\/\/doi.org\/10.1002\/ana.10336","journal-title":"Ann Neurol"},{"issue":"1","key":"5511_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0006-8993(98)01258-X","volume":"835","author":"JN Crawley","year":"1999","unstructured":"Crawley JN (1999) Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests1Published on the World Wide Web on 2 December 1998.1. Brain Res 835(1):18\u201326","journal-title":"Brain Res"},{"key":"5511_CR30","unstructured":"Bailey KR, Crawley JN (2009) Anxiety-related behaviors in mice. In: Buccafusco JJ (ed) Methods of behavior analysis in neuroscience. 2nd edn. Boca Raton (FL): CRC Press\/Taylor & Francis. Chapter 5"},{"key":"5511_CR31","doi-asserted-by":"publisher","unstructured":"Sunyer B, Patil S, H\u00f6ger H et al (2007) Barnes maze, a useful task to assess spatial reference memory in the mice. https:\/\/doi.org\/10.1038\/nprot.2007.390","DOI":"10.1038\/nprot.2007.390"},{"issue":"2","key":"5511_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1101\/lm.028076.112","volume":"20","author":"TP O'Leary","year":"2013","unstructured":"O\u2019Leary TP, Brown RE (2013) Optimization of apparatus design and behavioral measures for the assessment of visuo-spatial learning and memory of mice on the Barnes maze. Learn Mem 20(2):85\u201396","journal-title":"Learn Mem"},{"issue":"6","key":"5511_CR33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1101\/lm.334306","volume":"13","author":"FE Harrison","year":"2006","unstructured":"Harrison FE, Reiserer RS, Tomarken AJ, McDonald MP (2006) Spatial and nonspatial escape strategies in the Barnes maze. Learn Mem 13(6):809\u2013819","journal-title":"Learn Mem"},{"issue":"9","key":"5511_CR34","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1017\/S1461145714000303","volume":"17","author":"CE Handford","year":"2014","unstructured":"Handford CE, Tan S, Lawrence AJ, Kim JH (2014) The effect of the mGlu5 negative allosteric modulator MTEP and NMDA receptor partial agonist D-cycloserine on Pavlovian conditioned fear. Int J Neuropsychopharmacol 17(9):1521\u20131532","journal-title":"Int J Neuropsychopharmacol"},{"issue":"9","key":"5511_CR35","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.euroneuro.2016.06.002","volume":"26","author":"NA Chen","year":"2016","unstructured":"Chen NA, Ganella DE, Bathgate RA, Chen A, Lawrence AJ, Kim JH (2016) Knockdown of corticotropin-releasing factor 1 receptors in the ventral tegmental area enhances conditioned fear. Eur Neuropsychopharmacol 26(9):1533\u20131540","journal-title":"Eur Neuropsychopharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05511-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T08:04:04Z","timestamp":1763539444000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05511-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5511"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05511-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the experiments were conducted in accordance with animal ethics approved by the University of Melbourne Animal Ethics Committee (AEC).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"PA is a senior scientific consultant to Alterity Therapeutics and the Chief Scientific Officer to Tessara Therapeutics. Neither company conducts activities that are relevant to the content of this manuscript, nor did they have any involvement in the work. SC has received payments from AbbVie, Biogen, Clarivate, Eisai and Lilly for educational and\/or consulting services. None of the other authors has competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"88"}}